Eton Pharmaceuticals (ETON) Asset Utilization Ratio (2020 - 2025)
Eton Pharmaceuticals (ETON) reported Asset Utilization Ratio of 0.81 for Q4 2025, up 16.7% on a YoY basis from 0.7 in Q4 2024, and up 19.23% sequentially from 0.68 in Q3 2025.
Eton Pharmaceuticals (ETON) Asset Utilization Ratio (2020 - 2025) Analysis & Trends
Eton Pharmaceuticals (ETON) has 6 years of Asset Utilization Ratio data on file, last reported at 0.81 in Q4 2025.
- For the quarter ending Q4 2025, Asset Utilization Ratio rose 16.7% year-over-year to 0.81; the trailing twelve-month figure through Dec 2025 stood at 0.81 (up 16.7% YoY), and the FY2025 full-year result was 0.95, up 31.4% from the prior year.
- Asset Utilization Ratio rose to 0.81 in Q4 2025, from 0.68 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 1.82 in Q1 2024 to a low of 0.42 in Q1 2021.
- A 5-year average of 0.93 and a median of 0.81 in 2025 frame the typical range for Asset Utilization Ratio.
- Across the five-year window, Asset Utilization Ratio soared 5397.33% in 2021 and plunged 66.77% in 2025, its largest moves.
- Tracing ETON's Asset Utilization Ratio over 5 years: stood at 0.81 in 2021, then grew by 10.0% to 0.89 in 2022, then soared by 92.65% to 1.71 in 2023, then tumbled by 59.28% to 0.7 in 2024, then grew by 16.7% to 0.81 in 2025.
- Business Quant data shows ETON's Asset Utilization Ratio at 0.81 in Q4 2025, 0.68 in Q3 2025, and 0.63 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.43 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.62 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.46 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.43 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.39 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.65 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.37 |
| 10 | Eton Pharmaceuticals | 1.19 Bn | 1.16 Bn | 13.10 Mn | 0.81 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.81 |
| Sep 30, 2025 | 0.68 |
| Jun 30, 2025 | 0.63 |
| Mar 31, 2025 | 0.60 |
| Dec 31, 2024 | 0.70 |
| Sep 30, 2024 | 1.69 |
| Jun 30, 2024 | 1.72 |
| Mar 31, 2024 | 1.82 |
| Dec 31, 2023 | 1.71 |
| Sep 30, 2023 | 1.05 |
| Jun 30, 2023 | 1.12 |
| Mar 31, 2023 | 0.97 |
| Dec 31, 2022 | 0.89 |
| Sep 30, 2022 | 0.82 |
| Jun 30, 2022 | 0.61 |
| Mar 31, 2022 | 0.48 |
| Dec 31, 2021 | 0.81 |
| Sep 30, 2021 | 0.56 |
| Jun 30, 2021 | 0.50 |
| Mar 31, 2021 | 0.42 |